FoRx Therapeutics AG
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors. (NCT07356453) | FoRx Therapeutics AG | 2025-07-22 |
Track FoRx Therapeutics AG automatically
Every clearance here is in the API, with alerts when new ones post.